Interested in vaccine clinical trials?

download, pfizer, clincal trials

Vaccine clinical trials aim to establish the safety and efficacy of a vaccine prior to it being licensed. They offer protection to both the users and the manufacturers.

Want to know more?

Here are two presentations from the World Vaccine Congress Washington 2012!

Novel strategies for improving early-stage vaccine clinical studies by Dr Doug Girgenti, Global Clinical Program Lead, Pfizer.

Presentation overview:

•    Concept of true "Phase 0" or "microdose" studies
•    Utility of supportive studies of novel early phase vaccine programs
•    Early -phase considerations for patient population-based vaccine programs

Download Dr Girgenti's presentation here!

Monitoring Safety in Vaccine Clinical Trials by Ann Wouters, Assistant Director, Clinical Scientist, Pfizer.

Presentation overview:

1.    Characteristics and design of vaccine study
a.    Adverse Event categories and reporting time lines
b.    Solicited Local and systemic reactogenicity
c.    Solicited laboratory parameters
2.    Unsolicited adverse event- events
3.    Safety Data Review Process
4.    Role of Data Monitoring Committees

Download Ann Wouter's presentation here!


For more updates on the vaccines industry, follow us on Twitter:  @vaccinenation or join our LinkedIn group: Vaccine Nation

Leave a Reply

Your email address will not be published. Required fields are marked *